Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.' Photograph: ANI Photo As India's COVID-19 daily case count dips below the 100-mark, approvals for......
''The future looks quite bleak unless we ramp up testing and start vaccinating on a war footing.' ' IMAGE: Beneficiaries stand in a long queue to receive the COVID-19 vaccine doses at a......
Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union health ministry said on Friday. IMAGE:......
The Serum Institute has disassociated itself from its executive director's statement that the government began the COVID-19 vaccination of multiple age groups without taking into consideration the......
'I'll give it to the vaccine manufacturers without guarantees, take the payment in advance and give me the supplies.''The moment you give me one lot of supply, I'll give you more.' IMAGE: A......
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and......
A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains. As we inch closer to getting a vaccine for......
Young Indian entrepreneurs hope to share some of the limelight too at the Hyderabad event.B Dasarath Reddy reports. New-age entrepreneurs, from Flipkart Executive Chairman Sachin Bansal to......
The 30-share Sensex surged 267 points to end at 28,335 and the 50-share Nifty gained 75 points to close at 8,477. The markets scaled fresh all-time highs led by a strong rally in banking shares......